Prescription Narcotic Cough Preparations And Expectorants MarketSize and Trends

Market Taxonomy

On the basis of type of cough, the global market is classified into:

Acute cough
Chronic cough

On the basis of end user, the global market is classified into:

Government and Private Hospitals
Medical Practitioners
Others

According to a report by National Center for Biotechnology Information, acute cough comes under top five complications of general practice. Acute cough or acute bronchitis is the fifth most frequent presentation in Australia and the U.S. Moreover, the report also suggests that in the U.K. almost 50 persons out of 100 suffer from acute cough. Moreover, acute cough results into to 10 ambulatory visits per 1000 patient, in the U.S. each year. Substantiation from general practice intelligence and the U.K. and U.S. morbidity surveys demonstrate that the cases of acute cough are increasing at an alarming rate. Therefore, the overall prescription narcotic cough preparations and expectorants market is expected to grow proportionately.

Rising incidences of pertussis will drive the overall prescription narcotic cough preparations and expectorants market

Pertussis or whooping cough is a respiratory disease which is highly contagious in nature. Uncontrollable and violent coughing can lead to death in extreme conditions. According to Centers for Disease Control and Prevention report, in 2014, 32,971 cases of whooping cough were reported. This is a 15% increase as compared 28,639 cases reported in 2013. The increased rate of pertussis was observed mostly in the adolescents (13 to 15 years). Pertussis is a condition that needs physician’s advice for treatment, thereby increasing the demand for prescription narcotic cough treatment market. Additionally, babies are affected by cough and in some cases this might become fatal. Increased awareness, availability of advanced drugs, and adoption of early detection and prevention of diseases will fuel the growth of the overall prescription narcotic cough preparations and expectorants market.